Gene: ZNF790
Official Full Name: zinc finger protein 790provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11975 | ZNF790 Knockout cell line (HEK293) | Human | ZNF790 | 1:3~1:6 | Negative | Online Inquiry |
ZNF790 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to lack the ZNF790 gene, which plays a crucial role in various biological processes, including transcription regulation and cellular differentiation. The establishment of these knockout cell lines involves state-of-the-art CRISPR-Cas9 technology, which enables precise gene editing to produce a reliable model for evaluating the function of ZNF790 in both physiological and pathological contexts.
The primary mechanism of action in ZNF790 knockout cell lines revolves around the complete ablation of the gene's expression, allowing researchers to investigate the consequences of ZNF790 loss on cellular behavior, signaling pathways, and gene expression profiles. This is particularly significant in studies examining cancer biology, stem cell differentiation, and neurodevelopmental disorders, where altered expression of ZNF790 has been implicated.
The scientific importance of ZNF790 knockout cell lines lies in their potential applications in both research and clinical settings. They serve as valuable tools for understanding gene function, validating therapeutic targets, and developing gene therapies. Moreover, they can aid in drug discovery efforts by providing a more accurate platform for assessing the efficacy and safety of new pharmaceutical agents.
One of the key advantages of our ZNF790 Gene Knockout Cell Lines is their high specificity and efficiency in gene disruption, which outweighs alternative models such as transient knockdowns or overexpression systems that may introduce confounding variables. These stable cell lines allow for consistent reproducibility and facilitate long-term studies essential for robust scientific conclusions.
Researchers and clinicians will find immense value in utilizing ZNF790 knockout cell lines as they represent an advanced approach to dissect complex gene interactions and mechanisms, potentially accelerating the development of innovative therapies. Our extensive expertise in genetic engineering and commitment to quality assurance ensures that our cell lines meet rigorous standards for reliability and reproducibility, making them an indispensable resource for advancing biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.